Johnson Fistel, PLLP Investigates Claims on Behalf of Alto Neuroscience, Inc. Long-Term Shareholders

Core Viewpoint - Johnson Fistel, PLLP is investigating potential claims against Alto Neuroscience, Inc. for alleged breaches of fiduciary duties by its officers and directors [1] Group 1: Allegations of Misconduct - A federal securities fraud class action complaint has been filed against Alto Neuroscience, alleging that the company made materially false and misleading statements regarding its business and operations [2] - The complaint specifically claims that ALTO-100 was less effective in treating Major Depressive Disorder (MDD) than previously communicated to investors, and that the company's clinical, regulatory, and commercial prospects were overstated [2] - As a result of these alleged misrepresentations, the company's public statements were deemed materially false and misleading at all relevant times [2] Group 2: Actions for Shareholders - Shareholders may pursue changes to the company's corporate governance practices, seek recovery of funds for the company, and request a court-approved incentive award at no cost [3] - Interested parties can join the action through a provided link or by contacting Johnson Fistel, PLLP directly [3] Group 3: About the Law Firm - Johnson Fistel, PLLP is a nationally recognized law firm that represents individual and institutional investors in shareholder derivative and securities class action lawsuits [4]